Proteasomal degradation of core protein variants from chronic hepatitis B patients

Journal of Medical Virology

Volumn 79, Issue 9, 2007, Pages 1312-1321

  Braun, Sabine ^a,d   Zajakina, Anna ^b   Aleksejeva, Jekaterina ^b   Sharipo, Anatoly ^b   Bruvere, Ruta ^b   Ose, Velta ^b   Pumpens, Paul ^b   Garoff, Henrik ^c   Meisel, Helga ^a   Kozlovska, Tatyana ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KLINIKUM AUGSBURG   (Germany)

Author keywords

Chronic hepatitis; HBc internal deletion; SFV vector

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; HEPATITIS B CORE ANTIGEN; LACTACYSTIN; LEUPEPTIN; PROTEASOME; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE DELETION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; PROTEIN VARIANT; STEADY STATE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL LINE, TUMOR; CRICETINAE; EPITOPES; GENES, VIRAL; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; SEQUENCE DELETION; TRANSFECTION;

EUKARYOTA; HEPATITIS B VIRUS; RABBIT FIBROMA VIRUS;

EID: 34547133722     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20939     Document Type: Article

References (34)

1. Ambagala AP, Solheim JC, Srikumaran S. 2005. Viral interference with MHC class I antigen presentation pathway: The battle continues. Vet Immunol Immunopathol 107:1-15.
2. Berglund P, Finzi D, Bennink JR, Yewdell JW. 2007. Viral Alteration of Cellular Translational Machinery Increases Defective Ribosomal Products (DRiPs). J Virol published online 25 April 2007.
3. Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, Guilhot S, Chisari FV. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 88:10445-10449.
4. Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, Schlicht HJ, Vitiello A, Chesnut RC, Fiaccadori F, Ferrari C. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 67:2376-2380.
5. Chain BM, Myers R. 2005. Variability and conservation in hepatitis B virus core protein. BMC Microbiol 5:33.
6. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29-60.
7. Coux O, Tanaka K, Goldberg AL. 1996. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
8. Dantuma NP, Sharipo A, Masucci MG. 2002. Avoiding proteasomal processing: The case of EB NA1. Curr Top Microbiol Immunol 269:23-36.
9. Gunther S, Baginski S, Kissel H, Reinke P, Kruger DH, Will H, Meisel H. 1996. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stage liver disease. Hepatology 24:751-758.
10. Gunther S, Piwon N, Jung A, Iwanska A, Schmitz H, Will H. 2000. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. Virology 273:286-299.
11. Hosono S, Tai PC, Wang W, Ambrose M, Hwang DG, Yuan TT, Peng BH, Yang CS, Lee CS, Shih C. 1995. Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 212:151-162.
12. Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. 1999. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 73:7231-7240.
13. Kim JH, Kang S, Kim J, Ahn BY. 2003. Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J Virol 77:7166-7173.
14. Koschel M, Thomssen R, Bruss V. 1999. Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J Virol 73:2153-2160.
15. Liljeström P, Garoff H. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 9:1356-1361.
16. Loureiro J, Ploegh HL. 2006. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Adv Immunol 92:225-305.
17. Lybarger L, Wang X, Harris M, Hansen TH. 2005. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr Opin Immunol 17:71-78.
18. Marinos G, Torre F, Gunther S, Thomas MG, Will H, Williams R, Naoumov NV. 1996. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 111:183-192.
19. Marschenz S, Endres AS, Brinckmann A, Heise T, Kristiansen G, Nurnberg P, Kruger DH, Gunther S, Meisel H. 2006. Functional analysis of complex Hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 131:765-780.
20. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chisari FV. 1993. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177:751-762.
21. Okamoto H, Wang Y, Tanaka T, Machida A, Miyakawa Y, Mayumi M. 1993. Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines. J Gen Virol 74:407-414.
22. Preikschat P, Borisova G, Borschukova O, Dislers A, Mezule G, Grens E, Kruger DH, Pumpens P, Meisel H. 1999. Expression, assembly competence and antigenic properties of hepatitis B virus core gene deletion variants from infected liver cells. J Gen Virol 80:1777-1788.
23. Preikschat P, Kazaks A, Dishlers A, Pumpens P, Kruger DH, Meisel H. 2000. Interaction of wild-type and naturally occurring deleted variants of hepatitis B virus core polypeptides leads to formation of mosaic particles. FEBS Lett 478:127-132.
24. Preikschat P, Gunther S, Reinhold S, Will H, Budde K, Neumayer HH, Kruger DH, Meisel H. 2002. Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients. Hepatology 35:466-477.
25. Pumpens P, Grens E. 2001. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 44:98-114.
26. Roingeard P, Romet-Lemonne JL, Leturcq D, Goudeau A, Essex M. 1990. Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. Virology 179:113-120.
27. Sharipo A, Imreh M, Leonchiks A, Imreh S, Masucci MG. 1998. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: A new mechanism for selective inhibition of proteolysis. Nat Med 4:939-944.
28. Sharipo A, Imreh M, Leonchiks A, Branden C, Masucci MG. 2001. cis-Inhibition of proteasomal degradation by viral repeats: Impact of length and amino acid composition. FEBS Lett 499:137-142.
29. Sijts AJ, Ruppert T, Rehermann B, Schmidt M, Koszinowski U, Kloetzel PM. 2000. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med 191:503-514.
30. Tsai SL, Chen MH, Yeh CT, Chu CM, Lin AN, Chiou FH, Chang TH, Liaw YF. 1996. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. J Clin Invest 97:577-584.
31. Wynne SA, Crowther RA, Leslie AG. 1999. The crystal structure of the human hepatitis B virus capsid. Mol Cell 3:771-780.
32. Yuan TT, Lin MH, Qiu SM, Shih C. 1998. Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation. J Virol 72:2168-2176.
33. Zajakina A, Kozlovska T, Bruvere R, Aleksejeva J, Pumpens P, Garoff H. 2004. Translation of hepatitis B virus (HBV) surface proteins from the HBV pregenome and precore RNAs in Semliki Forest virus-driven expression. J Gen Virol 85:3343-3351.
34. Zaldumbide A, Ossevoort M, Wiertz EJ, Hoeben RC. 2007. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma Herpes virus. Mol Immunol 44:1352-1360.